The role of gender on clearance of hepatitis C virus: a different story in an area endemic for hepatitis B and C

Por Dai, Chia‐Yen, Huang, Jee‐Fu, Hsieh, Ming‐Yen, Lee, Li‐Po, Ho, Chi‐Kung, Chuang, Wan‐Long, Yu, Ming‐Lung
Publicado em 2007

Links between triglyceride levels, hepatitis C virus infection and diabetes

Por Dai, Chia‐Yen, Huang, Jee‐Fu, Hsieh, Ming‐Yen, Lee, Li‐Po, Hou, Nai‐Jen, Yu, Ming‐Lung, Chuang, Wan‐Long
Publicado em 2007

High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study

Por Yu, Ming-Lung, Dai, Chia-Yen, Chen, Shinn-Cherng, Lee, Li-Po, Hsieh, Ming-Yen, Lin, Zu-Yau, Hsieh, Ming-Yuh, Wang, Liang-Yen, Tsai, Jung-Fa, Chang, Wen-Yu, Chuang, Wan-Long
Publicado em 2005

Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin

Por Dai, Chia-Yen, Chuang, Wan-Long, Chang, Wen-Yu, Chen, Shinn-Cherng, Lee, Li-Po, Hsieh, Ming-Yen, Hou, Nei-Jen, Lin, Zu-Yau, Hsieh, Ming-Yuh, Wang, Liang-Yen, Yu, Ming-Lung
Publicado no World J Gastroenterol (2005)

A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C

Por Yu, Ming‐Lung, Dai, Chia‐Yen, Huang, Jee‐Fu, Hou, Nai‐Jen, Lee, Li‐Po, Hsieh, Ming‐Yen, Chiu, Chang‐Fu, Lin, Zu‐Yau, Chen, Shinn‐Cherng, Hsieh, Ming‐Yuh, Wang, Liang‐Yen, Chang, Wen‐Yu
Publicado em 2007

The incidence and risks of liver biopsy in non‐cirrhotic patients: An evaluation of 3806 biopsies

Por Huang, Jee‐Fu, Hsieh, Ming‐Yen, Dai, Chia‐Yen, Hou, Nai‐Jen, Lee, Li‐Po, Lin, Zu‐Yau, Chen, Shinn‐Chern, Wang, Liang‐Yen, Hsieh, Ming‐Yuh, Chang, Wen‐Yu, Yu, Ming‐Lung, Chuang, Wan‐Long
Publicado em 2007